Cochrane Abstracts
Hyperimmune immunoglobulin for people with COVID‐19
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Hyperimmune Immunoglobulin for People With COVID‐19." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436671/all/Hyperimmune_immunoglobulin_for_people_with_COVID‐19.
Hyperimmune immunoglobulin for people with COVID‐19. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436671/all/Hyperimmune_immunoglobulin_for_people_with_COVID‐19. Accessed March 24, 2025.
Hyperimmune immunoglobulin for people with COVID‐19. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436671/all/Hyperimmune_immunoglobulin_for_people_with_COVID‐19
Hyperimmune Immunoglobulin for People With COVID‐19 [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436671/all/Hyperimmune_immunoglobulin_for_people_with_COVID‐19.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Hyperimmune immunoglobulin for people with COVID‐19
ID - 436671
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436671/all/Hyperimmune_immunoglobulin_for_people_with_COVID‐19
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
